Through this relationship, Conduit will gain access to cutting-edge predictive models and dashboards, enabling the Company to evaluate drug candidates, streamline clinical trials, and optimize asset ...

Largely forgotten today, Norbert Wiener’s science of “cybernetics”—the study of organisms and machines as mutually compatible feedback systems—captivated scholars and the public alike from the late ...

The use of cybernetic avatars (1) (CAs) will allow their operators to take part in social activities without being physically present at a particular location, thereby enhancing the efficiency of ...

Conduit Pharmaceuticals partners with SARBORG Limited to leverage artificial intelligence and cybernetics for optimizing key drug development processes, including drug repurposing, discovery, and ...

This innovative approach aims to reduce human error, cut costs, and improve efficiency, positioning Conduit for success across its current and future portfolio. By entering into this agreement with ...